The efficacy of intratympanic steroid injection for sudden sensorineural hearing loss

The efficacy of intratympanic steroid injection for sudden sensorineural hearing loss - The efficacy of intratympanic steroid injection for sudden sensorineural hearing loss

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000010454

Enrollment

Registered

2013-04-09

Start date

2013-04-09

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

sudden sensorineural hearing loss

Interventions

intratympanic steroid injection contorol

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with sudden sensorineural hearing loss

Exclusion criteria

Exclusion criteria: Hypertension and diabetes in a noncompensated status, history of ischemic disorders (stroke, heart attack), Meniere's disease, retrocochlear diseases, trauma, radiation-induced HL, or any other identifiable etiology responsible or triggering sudden HL

Design outcomes

Primary

Measure	Time frame
pure-tone average hearing recovery rate	—

Secondary

Measure	Time frame
speech discrimination sccore DPOAE level	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026